Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. - Test2 - elhamkhani - TriplyDB

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells.

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells.

http://www.wikidata.org/entity/Q36621899

about

Lysine supplementation is not effective for the prevention or treatment of feline herpesvirus 1 infection in cats: a systematic review Argininosuccinate synthase: at the center of arginine metabolism Role of arginine and its methylated derivatives in cancer biology and treatment.Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy Alternative fuels for cancer cells Drugging the addict: non-oncogene addiction as a target for cancer therapy Mass spectrometry-based proteomics turns quantitative Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections In silico proteome-wide amino aCid and elemental composition (PACE) analysis of expression proteomics data provides a fingerprint of dominant metabolic processes.Emerging PEGylated drugs.Amino acids regulate transgene expression in MDCK cells.Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling SCHEMA-designed variants of human Arginase I and II reveal sequence elements important to stability and catalysis.Methionine Deprivation Induces a Targetable Vulnerability in Triple-Negative Breast Cancer Cells by Enhancing TRAIL Receptor-2 Expression Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivation Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.Prevention of amino acid conversion in SILAC experiments with embryonic stem cells.Arginine deprivation affects glioblastoma cell adhesion, invasiveness and actin cytoskeleton organization by impairment of β-actin arginylation.RNA interference of argininosuccinate synthetase restores sensitivity to recombinant arginine deiminase (rADI) in resistant cancer cells Pegylated arginine deiminase: a novel anticancer enzyme agent.The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivo.Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines.Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy.Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells.An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice.Therapeutic interventions to disrupt the protein synthetic machinery in melanoma Arginine increases development of in vitro-produced porcine embryos and affects the protein arginine methyltransferase-dimethylarginine dimethylaminohydrolase-nitric oxide axis.Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth.An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo.Amino acid auxotrophy as a system of immunological control nodes.Arginine deprivation as a targeted therapy for cancer.IDENTIFYING CANCER SPECIFIC METABOLIC SIGNATURES USING CONSTRAINT-BASED MODELS.Oncogene-Selective Sensitivity to Synchronous Cell Death following Modulation of the Amino Acid Nutrient Cystine.Targeted cellular metabolism for cancer chemotherapy with recombinant arginine-degrading enzymes.Use of a Plackett-Burman statistical design to determine the effect of selected amino acids on monoclonal antibody production in CHO cells.Positioning of aminopeptidase inhibitors in next generation cancer therapy.Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges.Arginine deprivation, growth inhibition and tumour cell death: 2. Enzymatic degradation of arginine in normal and malignant cell cultures.Arginine deprivation, growth inhibition and tumour cell death: 3. Deficient utilisation of citrulline by malignant cells

P2860

Q22000632-2AC836E9-A831-4FEC-93CC-8F03529DA2A8 Q24620561-5A266228-5A4F-4779-8394-785EB50F28AD Q24805212-4D7E4DE2-EABF-4E16-9580-5670D091A02F Q26765461-1962A601-B7B2-4ACC-B38C-A8F4DC50088F Q26997591-F4D972CA-0175-4A1F-B2DA-F494174956EF Q28079559-E7486759-9418-4183-A05D-1DD125476077 Q28291379-5AAAC023-4CDC-4D0A-81DF-97A937AEE6B9 Q30040775-0EA5208E-052A-4397-BAB4-EAF940C12ED7 Q30659424-39A565EB-C77B-4206-A5C4-E5A071B0A8C4 Q33447691-F1D99EA8-2773-4F13-B397-199386DCAE0A Q33567966-AEDE3BDC-1857-4CF9-B2D2-D9F0A009C69C Q33710602-CFB2A7A2-841B-47C4-901A-3A147F8653A4 Q34318551-92C3D238-5FD5-4273-9CC3-1DC31AAA3690 Q34464915-2589FB6A-CCA8-4A34-8B9F-4F26F18BFC53 Q34568337-F8E49773-5E28-4995-BAC2-45E59D4C88AB Q34768395-B9D7575D-4A30-4CC6-9C44-80724F8E207E Q34779352-582E8C1D-19FF-4350-871B-0A3E66AAC06E Q34807813-8C5B4B9C-FA01-49DE-B588-CF73953A9DEC Q34832425-2340102F-0AFA-4747-99AB-AAC67D0FABFF Q34911774-2115A422-FFC8-490B-B062-59DAB526D858 Q35120347-D5905EE1-315D-488C-A9C3-DC69CF2A71CB Q35556985-AAFF1753-3EAC-437F-9BA6-2E1864E9239A Q35561304-A5DEC5E2-DEB3-43DE-A675-B8905A9CB5F2 Q35803555-EC3FE781-D5B3-40E5-9DD1-7FDE3E7EB90D Q36106835-C70B549F-3B03-4AE4-8D2A-039462EDC85E Q36328854-8FB2D127-438E-4B75-91D4-993F46D2CD08 Q36473355-53DE14EC-E8B7-41E9-93C1-E11C65E3A61B Q36501368-7021188E-016E-442E-A9D1-FCC7334903B1 Q36671753-B3E082C1-E9C2-4209-9BBE-613F68819101 Q36869275-DD75C23D-4504-48CA-B634-51E8F9E8CD20 Q36970801-E0FDF32D-6A1D-4D0B-82FD-EDD0DB12972C Q37160927-930CE724-3582-4B81-A35F-3A19510DF2BD Q37520927-8EFADB8B-A432-4FF5-B630-93DACE928BDA Q37723730-C84CDF96-59C4-44CC-9B89-6CEA963D847D Q37820202-18A1D29A-7566-4E3B-917A-15C4843F541C Q37929098-0D751F04-BDA4-4D1F-AF3E-ECFEC7AA39A0 Q38175346-E030964E-449A-4D0A-8BEB-12A10736BA0D Q38181070-6C346E47-AB8C-4B5E-B8DE-4179248D6B1E Q38310276-856D28A6-4DD5-4A6A-AB84-25A4E8513B12 Q38602768-C1991C6A-C688-42A0-930E-8850EC8EE8DF

P2860

Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells.

http://www.wikidata.org/entity/Q36621899

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Single amino acid (arginine) d ...... ansformed and malignant cells.

@ast

Single amino acid (arginine) d ...... ansformed and malignant cells.

@en

type

label

Single amino acid (arginine) d ...... ansformed and malignant cells.

@ast

Single amino acid (arginine) d ...... ansformed and malignant cells.

@en

prefLabel

Single amino acid (arginine) d ...... ansformed and malignant cells.

@ast

Single amino acid (arginine) d ...... ansformed and malignant cells.

@en

P1433

Q36621899-19A65AF6-2CE2-4DF1-8C09-D72F3264676C

P1476

Q36621899-4A20C4FB-BF43-48A0-98FB-1D3269D5AF33

P2093

Q36621899-1889EF82-70C8-4864-B238-099F7F0CCA5C

Q36621899-27F6E56F-054A-43AD-8269-25E3F1C80E6F

Q36621899-AC1897E7-4C8E-4316-8F39-FB7E08B4A854

Q36621899-E78642C6-B4C3-4D7A-A6D7-B2F729A09FE9

P2860

Q36621899-00FFBC06-6A7A-4A73-9389-9557EF94C0DF

Q36621899-0123FC19-A0A3-40A6-B290-B5346E00E6B8

Q36621899-076F354D-502B-43EA-BC77-865FE55098EE

Q36621899-0C441197-3127-45EE-990A-D88BBEB67E59

Q36621899-15B423C8-B9D6-4EC6-B52E-AA30435BDA04

Q36621899-18558A72-D460-47AB-AA9F-5DBBDD9397DB

Q36621899-2FECA5CD-6F3A-469F-8944-11599E4C8A27

Q36621899-371934E7-B15B-48D4-9160-A56158B277AF

Q36621899-3E36058C-0D48-4490-A5AC-948F6DF05ACF

Q36621899-4D60160C-CF43-45CF-B4D4-78AFEA7F3B41

P2888

Q36621899-3895EA39-080D-4435-9235-E19AD7AE867B

P304

Q36621899-6C1685FF-9E38-4311-898A-D59E6D4A82D3

P31

Q36621899-B09C35A5-71DB-49A0-861F-CE2FE791EDBC

P356

Q36621899-16C35DF8-C3A7-4281-83F4-2801ADCDEA3E

P407

Q36621899-16BE5A01-8E54-478C-A03E-57499BAC81EF

P433

Q36621899-E5B37254-5BEF-49B9-8C14-16C8BD0B8084

P478

Q36621899-25414241-3C55-4F52-8432-5D77BF382F11

P577

Q36621899-27399724-4339-4D72-B519-B55AD02D82AA

P5875

Q36621899-DFBC3A64-AB34-4D53-8457-B00831AE3385

P6179

Q36621899-D0EFA82F-F2F0-45E1-BF6C-72156686F0EE

P698

Q36621899-2E221830-247E-440B-BB5B-4A76825C5E86

P932

Q36621899-39AB1756-AB68-4B52-AA12-BBAA6F4DED75

P356

P1433

British Journal of Cancer

P1476

Single amino acid (arginine) d ...... ansformed and malignant cells.

@en

P2093

Lamb J

http://www.w3.org/2001/XMLSchema#string

Scott L

http://www.w3.org/2001/XMLSchema#string

Smith S

http://www.w3.org/2001/XMLSchema#string

Wheatley DN

http://www.w3.org/2001/XMLSchema#string

P2860

A restriction point for control of normal animal cell proliferation

G1 events and regulation of cell proliferation

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype.

The role of apoptosis in cell killing by cisplatin: a flow cytometric study.

The effects of arginine deficiency on lymphoma cells

Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation.

Regulation of initiation of DNA synthesis in Chinese hamster cells. I. Production of stable, reversible G1-arrested populations in suspension culture.

Continued initiation of DNA synthesis in arginine-deprived Chinese hamster ovary cells.

Arginine deprivation in KB cells. II. Characterization of the DNA synthesized during starvation.

P2888

P304

800-810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2000.1353

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12367767

http://www.w3.org/2001/XMLSchema#string

P6179

1030549530

http://www.w3.org/2001/XMLSchema#string

P698

10952786

http://www.w3.org/2001/XMLSchema#string

P932

2363527

http://www.w3.org/2001/XMLSchema#string